Aprea Therapeutics, Inc. (APRE) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $15.93M | -33.6% |
| 2024 | $23.98M | +5.9% |
| 2023 | $22.65M | -24.9% |
| 2022 | $30.16M | -46.9% |
| 2021 | $56.82M | -38.8% |
| 2020 | $92.81M | -30.5% |
| 2019 | $133.61M | +102.4% |
| 2018 | $66.02M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $15.93M | -33.6% |
| 2024 | $23.98M | +5.9% |
| 2023 | $22.65M | -24.9% |
| 2022 | $30.16M | -46.9% |
| 2021 | $56.82M | -38.8% |
| 2020 | $92.81M | -30.5% |
| 2019 | $133.61M | +102.4% |
| 2018 | $66.02M | — |